Evidence map›Paper›PMID 37058118›Full record

ArticleNeuro-oncology2023

Primary papillary epithelial tumor of the sella and posterior pituitary tumor show similar (epi)genetic features and constitute a single neuro-oncological entity.

Jing Feng, Zejun Duan, Kun Yao, Qiuping Gui, Xing Liu, Xingfu Wang, Zunguo Du, Liwei Shao, Benyan Zhang, Shanshan Cai and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Neuro-oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. DNA Methylation in Pituitary Adenomas: A Scoping Review.International journal of molecular sciences · 2025
    Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 1 country.

Jing FengDepartment of Pathology, Sanbo Brain Hospital, Capital Medical University, Haidian District, Beijing, China.
Zejun DuanDepartment of Pathology, Sanbo Brain Hospital, Capital Medical University, Haidian District, Beijing, China.
Kun YaoDepartment of Pathology, Sanbo Brain Hospital, Capital Medical University, Haidian District, Beijing, China.
Qiuping GuiThe Department of Pathology, Chinese PLA General Hospital (301 Hospital), Beijing, China.
Xing LiuDepartment of Pathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.
Xingfu WangDepartment of Pathology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
Zunguo DuDepartment of Pathology, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
Liwei ShaoThe Department of Pathology, Chinese PLA General Hospital (301 Hospital), Beijing, China.
Benyan ZhangDepartment of Pathology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Shanshan CaiDepartment of Pathology, the Second Affiliated Hospital of Fujian Medical University, Fuzhou, China.
Mingwang ZhuDepartment of Imaging, Sanbo Brain Hospital, Capital Medical University, Haidian District, Beijing, China.
Zhong Ma
Zejuan HuDepartment of Pathology, Sanbo Brain Hospital, Capital Medical University, Haidian District, Beijing, China.
Lei XiangDepartment of Pathology, Sanbo Brain Hospital, Capital Medical University, Haidian District, Beijing, China.
Xiaolong FanBeijing Key Laboratory of Gene Resource and Molecular Development, Laboratory of Neuroscience and Brain Development, School of Life Sciences Beijing Normal University, Beijing, China.
Xueling QiDepartment of Pathology, Sanbo Brain Hospital, Capital Medical University, Haidian District, Beijing, China.ORCID 0000-0002-5787-4951
Capital Medical University · CNChinese PLA General Hospital · CNFujian Medical University · CNBeijing Normal University · CNFudan University · CNShanghai Jiao Tong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background"Primary papillary epithelial tumor of the sella (PPETS)" is a recently described rare tumor entity of the central nervous system (CNS) with stereotypic location in the sella. Comprehensive molecular investigations and epigenetic profiles of PPETS have not been performed to date.

methodsWe report a comprehensive clinical, histopathologic, and molecular assessment of 5 PPETS cases in comparison with a cohort composed of 7 choroid plexus papilloma (CPP), 7 central neurocytoma (CN), 15 posterior pituitary tumor (PPT) including 4 pituicytoma, 6 granular cell tumors of the sellar region (GCT), and 5 spindle cell oncocytoma.

resultsAll PPETS had good outcomes. Immunohistochemically, PPETS tumors showed positive staining with TTF1, EMA, AE1/AE3, MAP2, and Vimentin, but were negatively stained with Syn, GFAP, CgA, and S100, and sporadically stained with Ki-67. In unsupervised hierarchical clustering and t-distributed stochastic neighbor embedding analyses of DNA-methylation data, PPETS and PPT tumors formed a distinct cluster irrespective of their histologic types. However, PPETS tumors did not cluster together with CPP and CN samples. Similar findings were obtained when our samples were projected into the reference cohort of the brain tumor classifier. Substantial fractions of the PPETS and PPT tumors shared broadly similar chromosomal copy number alterations. No mutations were detected using targeted next-generation sequencing.

conclusionsThough more cases are needed to further elucidate the molecular pathogenesis of these tumors, our findings indicate that PPETS and PPT tumors may constitute a single neurooncological entity.

Indexed as

Adenoma, OxyphilicNeoplasms, Glandular and EpithelialPituitary NeoplasmsCentral Nervous SystemDNA MethylationHumansDNA methylation profilemolecular classificationprimary papillary epithelial tumorsellaTTF1

Identifiers

PMID37058118
PMCPMC10398802
OpenAlexW4365479131

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.